Aristo Pharmaceuticals Pvt Ltd
Cefpodoxime (50mg/5ml) + Clavulanic Acid (31.25mg/5ml)
Monocef-O CV 50/31.25 Dry Syrup is a potent antibiotic used to treat a wide range of severe bacterial infections in children.
Powder for Oral Suspension
Monocef-O CV 50/31.25 Dry Syrup is a combination of two active medicines, Cefpodoxime Proxetil and Clavulanic Acid. It is given to children to treat a wide range of severe bacterial infections targeting the ear, throat, lungs, skin, and urinary tract. It works by inhibiting the growth of bacteria thereby preventing the infection spread.
Complete the entire course of antibiotics. Stopping too soon may cause the bacteria to multiply again or cause another infection.
No common side effects listed.
Monocef-O CV 50/31.25 Dry Syrup is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
Complete the entire course of antibiotics. Stopping too soon may cause the bacteria to multiply again or cause another infection. Encourage your child to drink plenty of water in case diarrhea develops as a side effect. Never give Monocef-O CV 50/31.25 Dry Syrup until and unless prescribed by the doctor. Do not give Monocef-O CV 50/31.25 Dry Syrup to treat common cold and flu-like symptoms caused by viruses. Stop Monocef-O CV 50/31.25 Dry Syrup immediately if your child develops an itchy rash, facial swelling, or breathing difficulty.
If you suspect an overdose, it is essential to consult your child's doctor immediately. While an extra dose of Monocef-O CV 50/31.25 Dry Syrup is unlikely to cause harm, an overdose can increase the risk of side effects and potentially worsen your child's condition.
Yes, serious side effects of Monocef-O CV 50/31.25 Dry Syrup can include persistent vomiting, kidney damage, allergy, diarrhea, and severe gastrointestinal infections. If your child experiences any of these symptoms, consult their doctor for guidance and support.
Monocef-O CV 50/31.25 Dry Syrup may interact with other medicines or substances. It is crucial to inform your child's doctor about any other medications they are taking before starting Monocef-O CV 50/31.25 Dry Syrup. Additionally, consult with your child's doctor before giving any other medicines to your child.
Antibiotics like Monocef-O CV 50/31.25 Dry Syrup do not typically interfere with vaccine ingredients or cause adverse reactions in children who have recently been vaccinated. However, it is recommended to wait until your child has recovered from their illness before receiving a vaccine. Once they have recovered, the vaccine can be administered.
Your child's doctor may recommend periodic kidney function tests and liver function tests to monitor their condition while taking Monocef-O CV 50/31.25 Dry Syrup long-term.
Children may experience stomach upset or diarrhea while taking antibiotics like Monocef-O CV 50/31.25 Dry Syrup. This is because antibiotics can disrupt the balance of good bacteria in the gastrointestinal tract, increasing the risk of developing other infections. If your child develops diarrhea while taking Monocef-O CV 50/31.25 Dry Syrup, consult their doctor for guidance on the next steps. In some cases, the doctor may adjust the dose.